- The recommended dose does not depend on the anesthetic regimen.
- Administer BRIDION intravenously as a single bolus injection. The bolus injection may be given over 10 seconds into an existing intravenous line. BRIDION has only been administered as a single bolus injection in clinical trials.
No dose adjustments of BRIDION required in these special patient populations
- Geriatric patients with normal organ function
- Patients diagnosed with or who have a history of pulmonary complications
- Patients diagnosed with or who have a history of cardiac disease (eg, patients with ischemic heart disease, chronic heart failure, or arrhythmia)
- Patients with mild to moderate renal impairment
Convenient single-dose vials
2-mL vial 200 mg BRIDION (sugammadex)
5-mL vial 500 mg BRIDION (sugammadex)
Vials not shown at actual size.
Each single-use vial contains a concentration of 100 mg/mL of sugammadex.
Vials include a peel-off label that can be applied to the syringe.
Drug compatibility
- May inject BRIDION into the intravenous line of a running infusion with the following intravenous solutions:
- 0.9% sodium chloride
- 5% dextrose
- 0.45% sodium chloride and 2.5% dextrose
- Ringer’s solution
- Isolyte P with 5% dextrose
- Ringer’s lactate solution
- 5% dextrose in 0.9% sodium chloride
- Ensure the infusion line is adequately flushed (eg, with 0.9% sodium chloride) between administration of BRIDION and other drugs.
- Do not mix BRIDION with other products except those listed above.
- BRIDION is physically incompatible with verapamil, ondansetron, and ranitidine.